Company Filing History:
Years Active: 2011
Title: Kazue Miyaji: Innovator in Cell Culture Technology
Introduction
Kazue Miyaji is a prominent inventor based in Ikeda, Japan. She has made significant contributions to the field of biotechnology, particularly in the production of viruses using cultured cells. Her innovative work has led to advancements that could impact various medical applications.
Latest Patents
Kazue Miyaji holds a patent for "Methods for the production of hemagglutinating virus of Japan and adenovirus using cultured cells." This patent discloses a novel cell suited for mass production of the Hemagglutinating Virus of Japan (HVJ). The human cell, which originates from a transformed human kidney cell line, has a doubling time of not more than 40 hours in logarithmic growth phase in suspension culture in a serum-free medium. The cell exhibits freeze-recovery properties and can achieve a maximum density of viable cells in suspension culture of not less than 10 cells/mL, allowing HVJ to grow effectively.
Career Highlights
Kazue Miyaji has dedicated her career to research and development in the field of cell culture technology. Her work at Genomidea Inc. has positioned her as a leader in the industry. She has focused on creating methods that enhance the efficiency of virus production, which is crucial for vaccine development and other therapeutic applications.
Collaborations
Kazue has collaborated with notable colleagues, including Takahiro Yano and Tetsuji Nagasawa. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Kazue Miyaji's contributions to biotechnology through her innovative patent and work at Genomidea Inc. highlight her role as a key figure in advancing cell culture technology. Her research has the potential to significantly impact the production of important viruses for medical use.